{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where agency_id = \"DEA\" and document_type = \"Rule\" sorted by posted_date descending", "rows": [["DEA_FRDOC_0001-0508", "DEA", "DEA_FRDOC_0001", "Designation of Propionyl Chloride as a List I Chemical", "Rule", null, "2026-03-10T04:00:00Z", 2026, 3, "2026-03-10T04:00:00Z", null, "2026-03-10T16:55:22Z", "2026-04657", 0, 0, "09000064b9206be3"], ["DEA_FRDOC_0001-0507", "DEA", "DEA_FRDOC_0001", "Schedules of Controlled Substances: Placement of Clonazolam, Diclazepam, Etizolam, Flualprazolam, and Flubromazolam in Schedule I of the Controlled Substances Act", "Rule", null, "2026-03-02T05:00:00Z", 2026, 3, "2026-03-02T05:00:00Z", null, "2026-03-02T18:40:50Z", "2026-04112", 0, 0, "09000064b91e8fdf"], ["DEA_FRDOC_0001-0506", "DEA", "DEA_FRDOC_0001", "Registering Emergency Medical Services Agencies under the Protecting Patient Access to Emergency Medications Act of 2017", "Rule", null, "2026-02-05T05:00:00Z", 2026, 2, "2026-02-05T05:00:00Z", null, "2026-02-05T17:30:25Z", "2026-02288", 0, 0, "09000064b919298b"], ["DEA-2023-0057-0003", "DEA", "DEA-2023-0057", "Definition of Cannabimimetic Agents and Assignment of an Administration Controlled Substances Code Number for all Cannabimimetic Agents", "Rule", null, "2026-01-20T05:00:00Z", 2026, 1, "2026-01-20T05:00:00Z", null, "2026-01-20T23:44:45Z", "2026-00907", 0, 0, "09000064b9161314"], ["DEA-2025-0075-0014", "DEA", "DEA-2025-0075", "Schedules of Controlled Substances: Placement of 4-Fluoroamphetamine in Schedule I", "Rule", null, "2026-01-15T05:00:00Z", 2026, 1, "2026-01-15T05:00:00Z", null, "2026-01-16T20:17:00Z", "2026-00633", 0, 0, "09000064b9152a07"], ["DEA-2024-0118-0004", "DEA", "DEA-2024-0118", "Schedules of Controlled Substances: Placement of N-Pyrrolidino Metonitazene and N-Pyrrolidino Protonitazene in Schedule I", "Rule", null, "2026-01-12T05:00:00Z", 2026, 1, "2026-01-12T05:00:00Z", null, "2026-01-13T02:58:59Z", "2026-00362", 0, 0, "09000064b913658f"], ["DEA-2023-0029-41937", "DEA", "DEA-2023-0029", "Fourth Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications", "Rule", null, "2025-12-31T05:00:00Z", 2025, 12, "2025-12-31T05:00:00Z", null, "2026-01-13T03:01:01Z", "2025-24123", 0, 0, "09000064b9113f32"], ["DEA-2023-0147-0004", "DEA", "DEA-2023-0147", "Schedules of Controlled Substances: Placement of N-Desethyl Isotonitazene and N-Piperidinyl Etonitazene in Schedule I", "Rule", null, "2025-12-23T05:00:00Z", 2025, 12, "2025-12-23T05:00:00Z", null, "2026-01-06T01:10:17Z", "2025-23717", 0, 0, "09000064b91067de"], ["DEA-2025-0918-0001", "DEA", "DEA-2025-0918", "Schedules of Controlled Substances: Extension of Temporary Placement of 4F-MDMB-BUTICA, ADB-4en-PINACA, 5F-EDMB-PICA, and MMB-FUBICA in Schedule I of the Controlled Substances Act", "Rule", null, "2025-12-16T05:00:00Z", 2025, 12, "2025-12-16T05:00:00Z", null, "2025-12-16T21:28:16Z", "2025-22960", 0, 0, "09000064b90da7df"], ["DEA-2025-0555-0055", "DEA", "DEA-2025-0555", "Schedules of Controlled Substances: Extension of Temporary Placement of MDMB-4en-PINACA in Schedule I", "Rule", null, "2025-12-11T05:00:00Z", 2025, 12, "2025-12-11T05:00:00Z", null, "2025-12-11T19:41:46Z", "2025-22540", 0, 0, "09000064b90c55b5"], ["DEA-2025-0852-0002", "DEA", "DEA-2025-0852", "Schedules of Controlled Substances: Extension of Temporary Placement of CUMYL-PEGACLONE in Schedule I", "Rule", null, "2025-12-11T05:00:00Z", 2025, 12, "2025-12-11T05:00:00Z", null, "2025-12-11T19:46:09Z", "2025-22496", 0, 0, "09000064b90c55b7"], ["DEA-2024-0144-0006", "DEA", "DEA-2024-0144", "Schedules of Controlled Substances: Placement of 4-Chloromethcathinone in Schedule I", "Rule", null, "2025-11-17T05:00:00Z", 2025, 11, "2025-11-17T05:00:00Z", null, "2025-11-20T02:13:12Z", "2025-20004", 0, 0, "09000064b9085a3d"], ["DEA-2025-0588-0001", "DEA", "DEA-2025-0588", "Schedules of Controlled Substances: Temporary Placement of ethyleneoxynitazene, methylenedioxynitazene, 5-methyl etodesnitazene, N-desethyl etonitazene, N-desethyl protonitazene, N,N-dimethylamino etonitazene, and N-pyrrolidino isotonitazene in Schedule I", "Rule", null, "2025-10-15T04:00:00Z", 2025, 10, "2025-10-15T04:00:00Z", null, "2025-10-17T03:23:35Z", "2025-19542", 0, 0, "09000064b901aa49"], ["DEA-2025-0558-0001", "DEA", "DEA-2025-0558", "Requiring Online Submission of Applications for and Renewals of DEA Registration; Correction", "Rule", null, "2025-10-02T04:00:00Z", 2025, 10, "2025-10-02T04:00:00Z", null, "2025-10-03T01:30:04Z", "2025-19292", 0, 0, "09000064b8ff064c"], ["DEA-2023-0016-0010", "DEA", "DEA-2023-0016", "Controlled Substances Ordering System Modernization", "Rule", null, "2025-10-02T04:00:00Z", 2025, 10, "2025-10-02T04:00:00Z", null, "2025-10-03T01:31:47Z", "2025-19325", 0, 0, "09000064b8ff074c"], ["DEA-2025-0556-0001", "DEA", "DEA-2025-0556", "Specific Listing for 1-boc-4-piperidone, a Currently Controlled List I Chemical", "Rule", null, "2025-10-02T04:00:00Z", 2025, 10, "2025-10-02T04:00:00Z", null, "2025-10-03T01:20:48Z", "2025-19349", 0, 0, "09000064b8ff07c5"], ["DEA-2024-0148-0006", "DEA", "DEA-2024-0148", "Schedules of Controlled Substances: Placement of Seven Specific Fentanyl-Related Substances in Schedule I", "Rule", null, "2025-09-18T04:00:00Z", 2025, 9, "2025-09-18T04:00:00Z", null, "2025-10-03T01:28:48Z", "2025-18103", 0, 0, "09000064b8fb0ed1"], ["DEA-2024-0118-0003", "DEA", "DEA-2024-0118", "Schedules of Controlled Substances: Temporary Placement of N-pyrrolidino metonitazene and N-pyrrolidino protonitazene in Schedule I", "Rule", null, "2025-08-15T04:00:00Z", 2025, 8, "2025-08-15T04:00:00Z", null, "2025-08-15T17:55:48Z", "2025-15566", 0, 0, "09000064b8f008ec"], ["DEA-2025-0192-0003", "DEA", "DEA-2025-0192", "Specific Listing for Dipentylone, A Currently Controlled Schedule I Substance", "Rule", null, "2025-08-08T04:00:00Z", 2025, 8, "2025-08-08T04:00:00Z", null, "2025-09-10T04:16:28Z", "2025-15177", 0, 0, "09000064b8ef0c9b"], ["DEA-2022-0145-0005", "DEA", "DEA-2022-0145", "Schedules of Controlled Substances: Extension of Temporary Placement of Clonazolam, Diclazepam, Etizolam, Flualprazolam, and Flubromazolam in Schedule I", "Rule", null, "2025-07-25T04:00:00Z", 2025, 7, "2025-07-25T04:00:00Z", null, "2025-07-25T16:18:35Z", "2025-14037", 0, 0, "09000064b8e9cab5"], ["DEA-2024-0026-0002", "DEA", "DEA-2024-0026", "Schedules of Controlled Substances: Placement of 2-Methyl AP-237 in Schedule I; Correction", "Rule", null, "2025-06-03T00:00:00Z", 2025, 6, "2025-06-03T00:00:00Z", null, "2025-06-03T21:07:54Z", "2025-09989", 0, 0, "09000064b8dceccb"], ["DEA-2023-0028-2951", "DEA", "DEA-2023-0028", "Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients", "Rule", null, "2025-03-24T04:00:00Z", 2025, 3, "2025-03-24T04:00:00Z", null, "2025-06-03T00:09:09Z", "2025-05007", 0, 0, "0900006486a29032"], ["DEA-2023-0028-2918", "DEA", "DEA-2023-0028", "Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients", "Rule", null, "2025-02-19T05:00:00Z", 2025, 2, "2025-02-19T05:00:00Z", "2025-03-01T04:59:59Z", "2025-03-01T23:55:45Z", "2025-02793", 0, 0, "0900006486971375"], ["DEA-2023-0028-2917", "DEA", "DEA-2023-0028", "Expansion of Buprenorphine Treatment via Telemedicine Encounter", "Rule", null, "2025-01-17T05:00:00Z", 2025, 1, "2025-01-17T05:00:00Z", null, "2025-01-21T13:53:50Z", "2025-01049", 0, 0, "09000064868e2eb2"], ["DEA-2023-0029-35464", "DEA", "DEA-2023-0029", "Continuity of Care via Telemedicine for Veterans Affairs Patients", "Rule", null, "2025-01-17T05:00:00Z", 2025, 1, "2025-01-17T05:00:00Z", null, "2025-01-21T13:54:28Z", "2025-01044", 0, 0, "09000064868e2ffd"], ["DEA-2024-0148-0001", "DEA", "DEA-2024-0148", "Schedules of Controlled Substances: Extension of Temporary Placement of Seven Specific Fentanyl-Related Substances in Schedule I", "Rule", null, "2024-12-30T05:00:00Z", 2024, 12, "2024-12-30T05:00:00Z", null, "2024-12-30T17:26:55Z", "2024-31130", 0, 0, "09000064868950c5"], ["DEA-2023-0029-35463", "DEA", "DEA-2023-0029", "Third Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications", "Rule", null, "2024-11-19T05:00:00Z", 2024, 11, "2024-11-19T05:00:00Z", null, "2024-11-27T19:50:54Z", "2024-27018", 0, 0, "090000648682777c"], ["DEA-2021-0031-0011", "DEA", "DEA-2021-0031", "Schedules of Controlled Substances: Placement of Butonitazene, Flunitazene, and Metodesnitazene in Schedule I", "Rule", null, "2024-10-25T04:00:00Z", 2024, 10, "2024-10-25T04:00:00Z", null, "2024-10-25T18:56:31Z", "2024-24635", 0, 0, "09000064867e36b5"], ["DEA-2023-0129-0013", "DEA", "DEA-2023-0129", "Schedules of Controlled Substances: Placement of Ethylphenidate in Schedule I", "Rule", null, "2024-10-22T04:00:00Z", 2024, 10, "2024-10-22T04:00:00Z", null, "2024-10-24T14:27:34Z", "2024-24083", 0, 0, "09000064867dd715"], ["DEA-2023-0149-0005", "DEA", "DEA-2023-0149", "Schedules of Controlled Substances: Placement of Zuranolone in Schedule IV", "Rule", null, "2024-08-14T04:00:00Z", 2024, 8, "2024-08-14T04:00:00Z", null, "2024-09-03T22:47:05Z", "2024-18087", 0, 0, "0900006486643896"], ["DEA-2023-0147-0003", "DEA", "DEA-2023-0147", "Schedules of Controlled Substances: Temporary Placement of N-Desethyl Isotonitazene and N-Piperidinyl Etonitazene in Schedule I", "Rule", null, "2024-07-29T04:00:00Z", 2024, 7, "2024-07-29T04:00:00Z", null, "2024-09-03T22:44:11Z", "2024-16391", 0, 0, "090000648660a036"], ["DEA-2021-0031-0006", "DEA", "DEA-2021-0031", "Schedules of Controlled Substances: Placement of Etodesnitazene, N-Pyrrolidino etonitazene, and Protonitazene in Schedule I", "Rule", null, "2024-04-11T04:00:00Z", 2024, 4, "2024-04-11T04:00:00Z", null, "2024-05-03T19:53:46Z", "2024-07684", 0, 0, "09000064864cd87a"], ["DEA-2021-0031-0008", "DEA", "DEA-2021-0031", "Schedules of Controlled Substances: Extension of Temporary Placement of Butonitazene, Flunitazene, and Metodesnitazene in Schedule I of the Controlled Substances Act", "Rule", null, "2024-04-11T04:00:00Z", 2024, 4, "2024-04-11T04:00:00Z", null, "2024-05-03T19:54:53Z", "2024-07689", 0, 0, "09000064864cd9c1"], ["DEA-2024-0026-0001", "DEA", "DEA-2024-0026", "Schedules of Controlled Substances: Placement of 2-Methyl AP-237 in Schedule I", "Rule", null, "2024-03-15T04:00:00Z", 2024, 3, "2024-03-15T04:00:00Z", null, "2024-03-19T12:47:48Z", "2024-05543", 0, 0, "090000648647c8be"], ["DEA-2024-0009-0001", "DEA", "DEA-2024-0009", "Conforming Amendment Regarding the Veterinary Medicine Mobility Act of 2014", "Rule", null, "2024-02-08T05:00:00Z", 2024, 2, "2024-02-08T05:00:00Z", null, "2024-02-08T15:01:26Z", "2024-02322", 0, 0, "09000064863f3b32"], ["DEA-2023-0169-0001", "DEA", "DEA-2023-0169", "Specific Listing for Currently Controlled Schedule I Substances", "Rule", null, "2023-12-13T05:00:00Z", 2023, 12, "2023-12-13T05:00:00Z", null, "2023-12-13T13:32:21Z", "2023-27292", 0, 0, "09000064863313c0"], ["DEA-2023-0049-0004", "DEA", "DEA-2023-0049", "Schedules of Controlled Substances: Temporary Placement of MDMB\u20134en\u2013PINACA, 4F\u2013MDMB\u2013BUTICA, ADB\u20134en\u2013PINACA, CUMYL\u2013PEGACLONE, 5F\u2013EDMB\u2013PICA, and MMB\u2013FUBICA into Schedule I", "Rule", null, "2023-12-12T05:00:00Z", 2023, 12, "2023-12-12T05:00:00Z", null, "2023-12-12T15:08:02Z", "2023-27243", 0, 0, "0900006486328332"], ["DEA-2023-0058-0012", "DEA", "DEA-2023-0058", "Schedules of Controlled Substances: Placement of Nine Specific Fentanyl-Related Substances in Schedule I", "Rule", null, "2023-12-07T05:00:00Z", 2023, 12, "2023-12-07T05:00:00Z", null, "2023-12-07T13:20:25Z", "2023-26694", 0, 0, "090000648630ac74"], ["DEA-2023-0059-0002", "DEA", "DEA-2023-0059", "Designation of Halides of 4-Anilinopiperidine as List I Chemicals", "Rule", null, "2023-10-31T04:00:00Z", 2023, 10, "2023-10-31T04:00:00Z", null, "2023-10-31T13:33:44Z", "2023-23927", 0, 0, "090000648619fb8c"], ["DEA-2023-0149-0001", "DEA", "DEA-2023-0149", "Schedules of Controlled Substances: Placement of Zuranolone in Schedule IV", "Rule", null, "2023-10-31T04:00:00Z", 2023, 10, "2023-10-31T04:00:00Z", "2023-12-01T04:59:59Z", "2023-11-16T02:00:24Z", "2023-23982", 0, 0, "090000648619fc3f"], ["DEA-2023-0146-0001", "DEA", "DEA-2023-0146", "Additions to Listing of Exempt Chemical Mixtures", "Rule", null, "2023-10-23T04:00:00Z", 2023, 10, "2023-10-23T04:00:00Z", "2023-11-23T04:59:59Z", "2023-10-24T00:51:02Z", "2023-23315", 0, 0, "090000648612376e"], ["DEA-2023-0029-35462", "DEA", "DEA-2023-0029", "Second Temporary Extension of COVID\u201319 Telemedicine Flexibilities for Prescription of Controlled Medications", "Rule", null, "2023-10-10T04:00:00Z", 2023, 10, "2023-10-10T04:00:00Z", null, "2023-10-11T12:17:00Z", "2023-22406", 0, 0, "0900006486098b08"], ["DEA-2019-0013-0260", "DEA", "DEA-2019-0013", "Management of Quotas for Controlled Substances and List I Chemicals", "Rule", null, "2023-08-31T04:00:00Z", 2023, 8, "2023-08-31T04:00:00Z", null, "2023-08-31T12:33:18Z", "2023-18885", 0, 0, "0900006485f1e8bc"], ["DEA-2021-0031-0005", "DEA", "DEA-2021-0031", "Schedules of Controlled Substances: Placement of Metonitazene in Schedule I", "Rule", null, "2023-08-18T04:00:00Z", 2023, 8, "2023-08-18T04:00:00Z", null, "2023-08-18T12:43:23Z", "2023-17778", 0, 0, "0900006485e84a8b"], ["DEA-2023-0106-0001", "DEA", "DEA-2023-0106", "Dispensing of Narcotic Drugs to Relieve Acute Withdrawal Symptoms of Opioid Use Disorder", "Rule", null, "2023-08-08T04:00:00Z", 2023, 8, "2023-08-08T04:00:00Z", null, "2023-08-18T12:40:11Z", "2023-16892", 0, 0, "0900006485dfb7fe"], ["DEA-2023-0098-0001", "DEA", "DEA-2023-0098", "Implementation of the Designer Anabolic Steroid Control Act", "Rule", null, "2023-08-01T04:00:00Z", 2023, 8, "2023-08-01T04:00:00Z", null, "2023-08-01T13:29:53Z", "2023-15747", 0, 0, "0900006485d9b704"], ["DEA-2021-0026-0185", "DEA", "DEA-2021-0026", "Initial Filling: Transfer of Electronic Prescriptions for Schedules II\u2013V Controlled Substances between Pharmacies", "Rule", null, "2023-07-27T04:00:00Z", 2023, 7, "2023-07-27T04:00:00Z", null, "2023-07-27T21:35:24Z", "2023-15847", 0, 0, "0900006485d5e100"], ["DEA-2022-0145-0004", "DEA", "DEA-2022-0145", "Schedules of Controlled Substances: Temporary Placement ofEtizolam, Flualprazolam, Clonazolam, Flubromazolam, and Diclazepam in Schedule I", "Rule", null, "2023-07-26T04:00:00Z", 2023, 7, "2023-07-26T04:00:00Z", null, "2025-07-30T17:42:01Z", "2023-15748", 0, 0, "0900006485d4c9a5"], ["DEA-2020-0035-0039", "DEA", "DEA-2020-0035", "Partial Filling of Prescriptions for Schedule II Controlled Substances", "Rule", null, "2023-07-21T04:00:00Z", 2023, 7, "2023-07-21T04:00:00Z", null, "2023-07-21T12:48:18Z", "2023-15508", 0, 0, "0900006485cf8fba"], ["DEA-2020-0038-0006", "DEA", "DEA-2020-0038", "Schedules of Controlled Substances: Placement of Brorphine in Schedule I; Correction", "Rule", null, "2023-07-19T04:00:00Z", 2023, 7, "2023-07-19T04:00:00Z", null, "2023-07-19T15:15:05Z", "2023-15249", 0, 0, "0900006485cdb926"], ["DEA-2020-0022-0024", "DEA", "DEA-2020-0022", "Reporting Theft or Significant Loss of Controlled Substances", "Rule", null, "2023-06-22T04:00:00Z", 2023, 6, "2023-06-22T04:00:00Z", null, "2023-06-22T15:34:58Z", "2023-13085", 0, 0, "0900006485bb0971"], ["DEA-2023-0029-35460", "DEA", "DEA-2023-0029", "Temporary Extension of COVID\u201319 Telemedicine Flexibilities for Prescription of Controlled Medications", "Rule", null, "2023-05-10T04:00:00Z", 2023, 5, "2023-05-10T04:00:00Z", null, "2023-05-10T13:01:17Z", "2023-09936", 0, 0, "09000064859ed53c"], ["DEA-2022-0102-0005", "DEA", "DEA-2022-0102", "Designation of a List I Chemical: 4-Piperidone", "Rule", null, "2023-04-12T04:00:00Z", 2023, 4, "2023-04-12T04:00:00Z", null, "2023-04-12T12:28:23Z", "2023-07538", 0, 0, "090000648593437e"], ["DEA-2023-0056-0001", "DEA", "DEA-2023-0056", "Specific Listing for Eutylone, a Currently Controlled Schedule I Substance", "Rule", null, "2023-04-10T04:00:00Z", 2023, 4, "2023-04-10T04:00:00Z", null, "2023-04-10T14:31:00Z", "2023-07335", 0, 0, "090000648591b81a"], ["DEA-2020-0038-0005", "DEA", "DEA-2020-0038", "Schedules of Controlled Substances: Placement of Brorphine in Schedule I", "Rule", null, "2023-03-06T05:00:00Z", 2023, 3, "2023-03-06T05:00:00Z", null, "2023-03-07T14:27:36Z", "2023-04364", 0, 0, "09000064857608c9"], ["DEA-2022-0068-0003", "DEA", "DEA-2022-0068", "Schedules of Controlled Substances: Removal of Fenfluramine from Control", "Rule", null, "2022-12-23T05:00:00Z", 2022, 12, "2022-12-23T05:00:00Z", null, "2022-12-23T13:05:30Z", "2022-27400", 0, 0, "0900006485550c29"], ["DEA-2021-0013-0006", "DEA", "DEA-2021-0013", "Schedules of Controlled Substances: Placement of Methiopropamine in Schedule I", "Rule", null, "2022-12-09T05:00:00Z", 2022, 12, "2022-12-09T05:00:00Z", null, "2022-12-12T14:18:13Z", "2022-26805", 0, 0, "090000648552a6b4"], ["DEA-2022-0137-0001", "DEA", "DEA-2022-0137", "2023 Established APQ", "Rule", null, "2022-12-02T05:00:00Z", 2022, 12, "2022-12-02T05:00:00Z", null, "2022-12-02T14:49:04Z", null, 0, 0, "09000064855122e6"], ["DEA-2020-0027-0007", "DEA", "DEA-2020-0027", "Default Provisions for Hearing Proceedings Relating to the Revocation, Suspension, or Denial of a Registration; Correction", "Rule", null, "2022-11-29T05:00:00Z", 2022, 11, "2022-11-29T05:00:00Z", null, "2022-11-30T13:07:10Z", "2022-25823", 0, 0, "0900006485507c87"], ["DEA-2021-0012-0004", "DEA", "DEA-2021-0012", "Schedules of Controlled Substances: Placement of Mesocarb in Schedule I", "Rule", null, "2022-11-22T05:00:00Z", 2022, 11, "2022-11-22T05:00:00Z", null, "2022-11-22T13:27:04Z", "2022-25219", 0, 0, "09000064854fbb4f"], ["DEA-2021-0025-0010", "DEA", "DEA-2021-0025", "Schedules of Controlled Substances: Removal of [18F]FP-CIT from Control", "Rule", null, "2022-11-21T05:00:00Z", 2022, 11, "2022-11-21T05:00:00Z", null, "2022-11-21T13:27:57Z", "2022-25212", 0, 0, "09000064854f8554"], ["DEA-2020-0015-0013", "DEA", "DEA-2020-0015", "Schedules of Controlled Substances: Placement of Zipeprol in Schedule I", "Rule", null, "2022-11-21T05:00:00Z", 2022, 11, "2022-11-21T05:00:00Z", null, "2022-11-21T13:29:53Z", "2022-25206", 0, 0, "09000064854f8125"], ["DEA-2021-0011-0007", "DEA", "DEA-2021-0011", "Schedules of Controlled Substances: Placement of Amineptine in Schedule I", "Rule", null, "2022-11-17T05:00:00Z", 2022, 11, "2022-11-17T05:00:00Z", null, "2022-11-17T13:05:24Z", "2022-25003", 0, 0, "09000064854bdf02"], ["DEA-2020-0027-0006", "DEA", "DEA-2020-0027", "Default Provisions for Hearing Proceedings Relating to the Revocation, Suspension, or Denial of a Registration", "Rule", null, "2022-11-14T05:00:00Z", 2022, 11, "2022-11-14T05:00:00Z", null, "2022-11-14T15:18:19Z", "2022-24425", 0, 0, "09000064854aab24"], ["DEA-2022-0134-0001", "DEA", "DEA-2022-0134", "Specific Listing for 1-boc-4-AP, a Currently Controlled List I Chemical", "Rule", null, "2022-11-09T05:00:00Z", 2022, 11, "2022-11-09T05:00:00Z", null, "2022-11-09T16:35:58Z", "2022-24155", 0, 0, "090000648549d59a"], ["DEA-2022-0051-0002", "DEA", "DEA-2022-0051", "Schedules of Controlled Substances: Placement of Ganaxolone in Schedule V", "Rule", null, "2022-11-09T05:00:00Z", 2022, 11, "2022-11-09T05:00:00Z", null, "2022-11-09T16:24:54Z", "2022-24157", 0, 0, "090000648549cc67"], ["DEA-2022-0133-0001", "DEA", "DEA-2022-0133", "Regulation Regarding Registration Exception for Officials; Technical Correction", "Rule", null, "2022-11-07T05:00:00Z", 2022, 11, "2022-11-07T05:00:00Z", null, "2022-11-07T14:10:14Z", "2022-24140", 0, 0, "0900006485492c7f"], ["DEA-2022-0025-0006", "DEA", "DEA-2022-0025", "Schedules of Controlled Substances: Placement of Daridorexant in Schedule IV", "Rule", null, "2022-09-30T04:00:00Z", 2022, 9, "2022-09-30T04:00:00Z", null, "2022-09-30T12:20:37Z", "2022-21253", 0, 0, "0900006485389e23"], ["DEA-2021-0010-0011", "DEA", "DEA-2021-0010", "Schedules of Controlled Substances: Placement of Serdexmethylphenidate in Schedule IV", "Rule", null, "2022-06-24T04:00:00Z", 2022, 6, "2022-06-24T04:00:00Z", null, "2022-06-24T12:22:19Z", "2022-13538", 0, 0, "090000648518b8dd"], ["DEA-2021-0030-0005", "DEA", "DEA-2021-0030", "Schedules of Controlled Substances: Placement of Methoxetamine (MXE) in Schedule I", "Rule", null, "2022-06-06T04:00:00Z", 2022, 6, "2022-06-06T04:00:00Z", null, "2022-06-06T13:54:29Z", "2022-11933", 0, 0, "0900006485141202"], ["DEA-2022-0050-0001", "DEA", "DEA-2022-0050", "Schedules of Controlled Substances: Placement of N-Ethylhexedrone, alpha-Pyrrolidinohexanophenone, 4-Methyl-alpha-ethylaminopentiophenone, 4\u2032-Methyl-alpha-pyrrolidinohexiophenone, alpha-Pyrrolidinoheptaphenone, and 4\u2032-Chloro-alpha-pyrrolidinovalerophenone in Schedule I", "Rule", null, "2022-06-01T04:00:00Z", 2022, 6, "2022-06-01T04:00:00Z", null, "2022-06-01T16:54:35Z", "2022-11740", 0, 0, "090000648511e3a3"], ["DEA-2022-0051-0001", "DEA", "DEA-2022-0051", "Schedules of Controlled Substances: Placement of Ganaxolone in Schedule V", "Rule", null, "2022-06-01T04:00:00Z", 2022, 6, "2022-06-01T04:00:00Z", "2022-07-02T03:59:59Z", "2022-06-01T16:56:42Z", "2022-11735", 0, 0, "090000648511e3a9"], ["DEA-2021-0031-0004", "DEA", "DEA-2021-0031", "Schedules of Controlled Substances: Temporary Placement of Butonitazene, Etodesnitazene, Flunitazene, Metodesnitazene, Metonitazene, N-Pyrrolidino etonitazene, and Protonitazene in Schedule I", "Rule", null, "2022-04-12T04:00:00Z", 2022, 4, "2022-04-12T04:00:00Z", null, "2022-04-12T12:55:17Z", "2022-07640", 0, 0, "090000648500fd5c"], ["DEA-2021-0005-0006", "DEA", "DEA-2021-0005", "Requiring Online Submission of Applications for and Renewals of DEA Registration", "Rule", null, "2022-04-11T04:00:00Z", 2022, 4, "2022-04-11T04:00:00Z", null, "2022-04-11T12:29:28Z", "2022-07570", 0, 0, "090000648500abee"], ["DEA-2019-0002-0010", "DEA", "DEA-2019-0002", "Schedules of Controlled Substances: Placement of 5F-EDMB-PINACA, 5F-MDMB-PICA, FUB-AKB48, 5F-CUMYL-PINACA, and FUB-144 in Schedule I", "Rule", null, "2022-04-07T04:00:00Z", 2022, 4, "2022-04-07T04:00:00Z", null, "2022-04-07T15:06:01Z", "2022-07320", 0, 0, "0900006484fff3b7"], ["DEA-2022-0025-0001", "DEA", "DEA-2022-0025", "Schedules of Controlled Substances: Placement of Daridorexant in Schedule IV", "Rule", null, "2022-04-07T04:00:00Z", 2022, 4, "2022-04-07T04:00:00Z", "2022-05-10T03:59:59Z", "2022-05-03T13:22:43Z", "2022-07322", 0, 0, "0900006484fff3ba"], ["DEA-2021-0009-0002", "DEA", "DEA-2021-0009", "Designation as a List I Chemical: Methyl alpha-phenylacetoacetate, a Precursor Chemical Used in the Illicit Manufacture of Phenylacetone, Methamphetamine, and Amphetamine", "Rule", null, "2021-11-18T05:00:00Z", 2021, 11, "2021-11-18T05:00:00Z", null, "2021-11-18T17:15:49Z", "2021-24952", 0, 0, "0900006484e5f385"], ["DEA-2020-0017-0005", "DEA", "DEA-2020-0017", "Schedules of Controlled Substances: Placement of Isotonitazene in Schedule I", "Rule", null, "2021-11-04T04:00:00Z", 2021, 11, "2021-11-04T04:00:00Z", null, "2021-11-04T12:13:37Z", "2021-23848", 0, 0, "0900006484e17dd9"], ["DEA-2021-0015-0001", "DEA", "DEA-2021-0015", "Schedules of Controlled Substances: Placement of Lemborexant in Schedule IV", "Rule", null, "2021-11-03T04:00:00Z", 2021, 11, "2021-11-03T04:00:00Z", null, "2021-11-05T13:57:18Z", "2021-04183", 0, 0, "0900006484a5c6dd"], ["DEA-2021-0024-0001", "DEA", "DEA-2021-0024", "Addition of the United States Space Force as a Registration Waiver and Registration Fee Exempt Military Entity", "Rule", null, "2021-09-17T04:00:00Z", 2021, 9, "2021-09-17T04:00:00Z", null, "2021-11-01T15:11:02Z", "2021-19984", 0, 0, "0900006484d8c25b"], ["DEA-2020-0009-0006", "DEA", "DEA-2020-0009", "Schedules of Controlled Substances: Placement of 4,4\u2032-DMAR in Schedule I", "Rule", null, "2021-08-12T04:00:00Z", 2021, 8, "2021-08-12T04:00:00Z", null, "2021-08-17T15:00:09Z", "2021-17052", 0, 0, "0900006484c48d9a"], ["DEA-2020-0036-0001", "DEA", "DEA-2020-0036", "Clarification Regarding the Supplier's DEA Registration Number on the Single-Sheet DEA Form 222", "Rule", null, "2021-07-20T04:00:00Z", 2021, 7, "2021-07-20T04:00:00Z", "2021-09-21T03:59:59Z", "2021-08-19T01:00:36Z", "2021-15323", 0, 0, "0900006484c03531"], ["DEA-2019-0009-0002", "DEA", "DEA-2019-0009", "Schedules of Controlled Substances: Extension of Temporary Placement of N-Ethylhexedrone, alpha-Pyrrolidinohexanophenone, 4-Methyl-alpha-ethylaminopentiophenone, 4\u2032-Methyl-alpha-pyrrolidinohexiophenone, alpha-Pyrrolidinoheptaphenone, and 4\u2032-Chloro-alpha-pyrrolidinovalerophenone in Schedule I of the Controlled Substances Act", "Rule", null, "2021-07-16T04:00:00Z", 2021, 7, "2021-07-16T04:00:00Z", null, "2021-10-29T17:47:11Z", "2021-15113", 0, 0, "0900006484bfbc0b"], ["DEA-2020-0005-0116", "DEA", "DEA-2020-0005", "Registration Requirements for Narcotic Treatment Programs with Mobile Components", "Rule", null, "2021-06-28T04:00:00Z", 2021, 6, "2021-06-28T04:00:00Z", null, "2021-07-28T19:03:18Z", "2021-13519", 0, 0, "0900006484bb969c"], ["DEA-2021-0023-0001", "DEA", "DEA-2021-0023", "Schedules of Controlled Substances: Placement of para-Methoxymethamphetamine (PMMA) in Schedule I", "Rule", null, "2021-06-25T04:00:00Z", 2021, 6, "2021-06-25T04:00:00Z", null, "2021-10-29T13:41:35Z", "2021-13460", 0, 0, "0900006484bb1b28"], ["DEA-2021-0022-0001", "DEA", "DEA-2021-0022", "Schedules of Controlled Substances: Specific Listing for 4F-MDMB-BINACA, a Currently Controlled Schedule I Substance", "Rule", null, "2021-06-22T04:00:00Z", 2021, 6, "2021-06-22T04:00:00Z", null, "2021-10-29T13:38:43Z", "2021-13040", 0, 0, "0900006484b9eb92"], ["DEA-2019-0004-0003", "DEA", "DEA-2019-0004", "Schedules of Controlled Substances: Placement of N-Ethylpentylone in Schedule I", "Rule", null, "2021-06-14T04:00:00Z", 2021, 6, "2021-06-14T04:00:00Z", null, "2021-08-18T13:25:42Z", "2021-12261", 0, 0, "0900006484b7a208"], ["DEA-2020-0032-0005", "DEA", "DEA-2020-0032", "Schedules of Controlled Substances: Placement of Oliceridine in Schedule II", "Rule", null, "2021-06-10T04:00:00Z", 2021, 6, "2021-06-10T04:00:00Z", null, "2021-06-14T19:51:45Z", "2021-11981", 0, 0, "0900006484b63b03"], ["DEA-2021-0021-0001", "DEA", "DEA-2021-0021", "Schedules of Controlled Substances: Placement of NM2201, 5F-AB-PINACA, 4-CN-CUMYL-BUTINACA, MMB-CHMICA, and 5F-CUMYL-P7AICA in Schedule I", "Rule", null, "2021-06-10T04:00:00Z", 2021, 6, "2021-06-10T04:00:00Z", null, "2021-10-29T13:35:32Z", "2021-11974", 0, 0, "0900006484b63b53"], ["DEA-2021-0020-0002", "DEA", "DEA-2021-0020", "Designation of 3,4-MDP-2-P methyl glycidate (PMK glycidate), 3,4-MD-2-P methyl glycidic acid (PMK glycidic acid), and alpha-phenylacetoacetamide (APAA) as List I Chemicals: Correction", "Rule", null, "2021-06-07T04:00:00Z", 2021, 6, "2021-06-07T04:00:00Z", null, "2021-10-29T13:22:51Z", "2021-11836", 0, 0, "0900006484b59277"], ["DEA-2020-0028-0007", "DEA", "DEA-2020-0028", "Schedules of Controlled Substances: Placement of Remimazolam in Schedule IV", "Rule", null, "2021-06-02T04:00:00Z", 2021, 6, "2021-06-02T04:00:00Z", null, "2021-08-18T13:34:04Z", "2021-11512", 0, 0, "0900006484b4cd8d"], ["DEA-2020-0003-0010", "DEA", "DEA-2020-0003", "Schedules of Controlled Substances: Placement of Lasmiditan in Schedule V", "Rule", null, "2021-05-24T04:00:00Z", 2021, 5, "2021-05-24T04:00:00Z", null, "2021-05-25T15:49:44Z", "2021-10827", 0, 0, "0900006484b2e413"], ["DEA-2021-0020-0001", "DEA", "DEA-2021-0020", "Designation of 3,4-MDP-2-P methyl glycidate (PMK glycidate), 3,4-MDP-2-P methyl glycidicacid (PMK glycidic acid), and alpha-phenylacetoacetamide (APAA) as List I Chemicals", "Rule", null, "2021-05-10T04:00:00Z", 2021, 5, "2021-05-10T04:00:00Z", null, "2021-10-29T13:18:05Z", "2021-09697", 0, 0, "0900006484ae1df4"], ["DEA-2021-0010-0001", "DEA", "DEA-2021-0010", "Schedules of Controlled Substances: Placement of Serdexmethylphenidate in Schedule IV", "Rule", null, "2021-05-07T04:00:00Z", 2021, 5, "2021-05-07T04:00:00Z", "2021-06-08T03:59:59Z", "2021-06-03T01:00:21Z", "2021-09738", 0, 0, "0900006484ad863b"], ["DEA-2021-0019-0001", "DEA", "DEA-2021-0019", "Schedules of Controlled Substances: Placement of Four Specific Fentanyl-Related Substances in Schedule I", "Rule", null, "2021-05-04T04:00:00Z", 2021, 5, "2021-05-04T04:00:00Z", null, "2021-10-29T13:14:00Z", "2021-09402", 0, 0, "0900006484aca7bd"], ["DEA-2021-0018-0001", "DEA", "DEA-2021-0018", "Schedules of Controlled Substances: Placement of 10 Specific Fentanyl-Related Substances in Schedule I", "Rule", null, "2021-04-27T04:00:00Z", 2021, 4, "2021-04-27T04:00:00Z", null, "2021-10-29T13:09:29Z", "2021-08720", 0, 0, "0900006484ab8209"], ["DEA-2021-0017-0001", "DEA", "DEA-2021-0017", "Schedules of Controlled Substances: Removal of Samidorphan From Control", "Rule", null, "2021-04-19T04:00:00Z", 2021, 4, "2021-04-19T04:00:00Z", null, "2021-10-29T11:35:21Z", "2021-07884", 0, 0, "0900006484aab9de"], ["DEA-2019-0002-0009", "DEA", "DEA-2019-0002", "Schedules of Controlled Substances: Extension of Temporary Placement of 5F-EDMB-PINACA, 5F-MDMB-PICA, FUB-AKB48, 5F-CUMYL-PINACA and FUB-144 in Schedule I of the Controlled Substances Act", "Rule", null, "2021-03-31T04:00:00Z", 2021, 3, "2021-03-31T04:00:00Z", null, "2021-05-17T13:12:19Z", "2021-06555", 0, 0, "0900006484a91bd6"], ["DEA-2021-0016-0001", "DEA", "DEA-2021-0016", "Schedules of Controlled Substances: Placement of cyclopentyl fentanyl, isobutyryl fentanyl, para-chloroisobutyryl fentanyl, para-methoxybutyryl fentanyl, and valeryl fentanyl in Schedule I; Correction", "Rule", null, "2021-03-31T04:00:00Z", 2021, 3, "2021-03-31T04:00:00Z", null, "2021-10-28T17:54:17Z", "2021-06596", 0, 0, "0900006484a91c1f"], ["DEA-2020-0038-0004", "DEA", "DEA-2020-0038", "Schedules of Controlled Substances: Temporary Placement of Brorphine in Schedule I", "Rule", null, "2021-03-01T05:00:00Z", 2021, 3, "2021-03-01T05:00:00Z", null, "2023-03-02T13:25:25Z", "2021-04242", 0, 0, "0900006484a5717c"]], "truncated": false, "filtered_table_rows_count": 287, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"agency_id\" = :p0 and \"document_type\" = :p1 order by posted_date desc limit 101", "params": {"p0": "DEA", "p1": "Rule"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=DEA&document_type=Rule", "results": [{"value": "DEA", "label": "DEA", "count": 287, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?document_type=Rule", "selected": true}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=DEA&document_type=Rule", "results": [{"value": "Rule", "label": "Rule", "count": 287, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=DEA", "selected": true}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=DEA&document_type=Rule", "results": [{"value": 2020, "label": 2020, "count": 32, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=DEA&document_type=Rule&posted_year=2020", "selected": false}, {"value": 2021, "label": 2021, "count": 24, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=DEA&document_type=Rule&posted_year=2021", "selected": false}, {"value": 2022, "label": 2022, "count": 21, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=DEA&document_type=Rule&posted_year=2022", "selected": false}, {"value": 2016, "label": 2016, "count": 20, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=DEA&document_type=Rule&posted_year=2016", "selected": false}, {"value": 2023, "label": 2023, "count": 20, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=DEA&document_type=Rule&posted_year=2023", "selected": false}, {"value": 2019, "label": 2019, "count": 19, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=DEA&document_type=Rule&posted_year=2019", "selected": false}, {"value": 2025, "label": 2025, "count": 19, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=DEA&document_type=Rule&posted_year=2025", "selected": false}, {"value": 2017, "label": 2017, "count": 17, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=DEA&document_type=Rule&posted_year=2017", "selected": false}, {"value": 2010, "label": 2010, "count": 14, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=DEA&document_type=Rule&posted_year=2010", "selected": false}, {"value": 2018, "label": 2018, "count": 14, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=DEA&document_type=Rule&posted_year=2018", "selected": false}, {"value": 2007, "label": 2007, "count": 13, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=DEA&document_type=Rule&posted_year=2007", "selected": false}, {"value": 2015, "label": 2015, "count": 13, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=DEA&document_type=Rule&posted_year=2015", "selected": false}, {"value": 2024, "label": 2024, "count": 10, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=DEA&document_type=Rule&posted_year=2024", "selected": false}, {"value": 2008, "label": 2008, "count": 9, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=DEA&document_type=Rule&posted_year=2008", "selected": false}, {"value": 2011, "label": 2011, "count": 9, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=DEA&document_type=Rule&posted_year=2011", "selected": false}, {"value": 2014, "label": 2014, "count": 9, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=DEA&document_type=Rule&posted_year=2014", "selected": false}, {"value": 2009, "label": 2009, "count": 6, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=DEA&document_type=Rule&posted_year=2009", "selected": false}, {"value": 2012, "label": 2012, "count": 6, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=DEA&document_type=Rule&posted_year=2012", "selected": false}, {"value": 2013, "label": 2013, "count": 6, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=DEA&document_type=Rule&posted_year=2013", "selected": false}, {"value": 2026, "label": 2026, "count": 6, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=DEA&document_type=Rule&posted_year=2026", "selected": false}], "truncated": false}}, "suggested_facets": [{"name": "posted_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=DEA&document_type=Rule&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=DEA&document_type=Rule&_facet_date=comment_start_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=DEA&document_type=Rule&_facet_date=last_modified"}], "next": "2021-03-01T05~3A00~3A00Z,DEA-2020-0038-0004", "next_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=DEA&document_type=Rule&_next=2021-03-01T05~3A00~3A00Z%2CDEA-2020-0038-0004&_sort_desc=posted_date", "private": false, "allow_execute_sql": true, "query_ms": 1817.8487489931285, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}